MDLZ vs ZYME · P/E 30, rev $38.54B vs rev $106.0M
Mondelez International Inc (MDLZ) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Mondelez International Inc (MDLZ) is a confectioners company listed on NASDAQ.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported MDLZ revenue for 2025-12-31 was $38.54B. Net income was $2.45B. Revenue was up 5.8% from 2024-12-31 to 2025-12-31. MDLZ currently screens at market cap $78.12B and trailing P/E 30.1.
Latest reported ZYME revenue for 2025-12-31 was $106.0M. Net income was -$81.1M. Revenue was up 38.9% from 2024-12-31 to 2025-12-31. ZYME currently screens at market cap $1.68B.
MDLZ currently screens at market cap $78.12B and trailing P/E 30.1. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the MDLZ and ZYME stock pages for the full models.
Not investment advice.